{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:20:56Z","timestamp":1767838856806,"version":"3.49.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[1995,9,1]],"date-time":"1995-09-01T00:00:00Z","timestamp":809913600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[1995,9]]},"DOI":"10.1007\/bf02210686","type":"journal-article","created":{"date-parts":[[2005,10,6]],"date-time":"2005-10-06T04:53:39Z","timestamp":1128574419000},"page":"32-39","source":"Crossref","is-referenced-by-count":39,"title":["Nandrolone decanoate: Pharmacological properties and therapeutic use in osteoporosis"],"prefix":"10.1007","volume":"14","author":[{"given":"P.","family":"Geusens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02210686_CR1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1055\/s-2008-1040579","volume":"7","author":"K.G. Ishak","year":"1987","unstructured":"Ishak, K.G., Zimmerman, H.J. Hepatotoxic effects of the anabolic\/androgenic steroids. Semin Liver Dis 1987, 7, 230\u2013236.","journal-title":"Semin Liver Dis"},{"key":"BF02210686_CR2","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/0026-0495(80)90159-6","volume":"29","author":"J.D. Wislon","year":"1980","unstructured":"Wislon, J.D., Griffin, J.E. The use and misuse of androgens. Metabolism 1980, 29, 1278\u20131295.","journal-title":"Metabolism"},{"key":"BF02210686_CR3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1210\/jcem-67-5-937","volume":"67","author":"J.R. Buchanan","year":"1988","unstructured":"Buchanan, J.R., Hospodar, P., Myers, C., et al. Effect of excess endogenous androgens on bone density in young women. J Clin Endocrinol Metab 1988, 67, 937\u2013943.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02210686_CR4","first-page":"177","volume":"21","author":"D.H. Marshall","year":"1977","unstructured":"Marshall, D.H., Crilly, R.G., Nordin, B.E.C. Androgen and oestrogen levels in normal and osteoporotic postmenopausal women. Br Med J 1977, 21, 177.","journal-title":"Br Med J"},{"key":"BF02210686_CR5","doi-asserted-by":"crossref","unstructured":"Johnston, Jr., C.C., Slemenda, C.W. The role of testosterone in skeletal integrity. (Abstract). 5th Sydney Bone Symposium 1990, April 23\u201325, S282.","DOI":"10.1016\/0169-6009(90)90305-Y"},{"key":"BF02210686_CR6","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/bmj.294.6575.798","volume":"294","author":"J.P. Devogelaer","year":"1987","unstructured":"Devogelaer, J.P., Crabb\u00e9, J., Nagant de Deuxchaisnes, C. Bone mineral density in Addison's disease: evidence for an effect of adrenal androgens on bone mass. Br Med J 1987, 294, 798\u2013800.","journal-title":"Br Med J"},{"key":"BF02210686_CR7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0378-5122(84)90002-1","volume":"6","author":"C. Longcope","year":"1984","unstructured":"Longcope, C., Baker, R.S., Hui, S.L., et al. Androgen and estrogen dynamics in women with vertebral crush fractures. Maturitas 1984, 6, 309\u2013318.","journal-title":"Maturitas"},{"key":"BF02210686_CR8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/jcem-54-1-115","volume":"54","author":"B.J. Davidson","year":"1982","unstructured":"Davidson, B.J., Ross, R.K., Paganini-Hill, A., et al. Total and free estrogens and androgens in postmenopausal women with hip fractures. J Clin Endocrinol and Metab 1982, 54, 115\u2013120.","journal-title":"J Clin Endocrinol and Metab"},{"key":"BF02210686_CR9","first-page":"1540","volume":"27","author":"P. Geusens","year":"1986","unstructured":"Geusens, P., Dequeker, J., Verstraeten, A., et al. Age-, sex- and menopause-related changes of vertebral and peripheral bone: population study using dual and single photonabsorptiometry and radiogrammetry. J Nucl Med 1986, 27, 1540\u20131549.","journal-title":"J Nucl Med"},{"key":"BF02210686_CR10","first-page":"75","volume":"9","author":"W.A. Kalender","year":"1989","unstructured":"Kalender, W.A., Felsenberg, D., Louis, O., Lopez, P., Klotz, E., Osteaux, M., Fraga, J. Reference values for trabecular and cortical vertebral bone density in single and dual-energy quantitative computed tomography. Eur J Radiol 1989, 9, 75\u201380.","journal-title":"Eur J Radiol"},{"key":"BF02210686_CR11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF00297293","volume":"50","author":"T.J. Beck","year":"1992","unstructured":"Beck, T.J., Ruff, C.B., Scott, W.W., Plato, C.C., Tobin, J.D., Quan, C.A. Sex differences in geometry of the femoral neck with aging: A structural analysis of bone mineral data. Calcif Tissue Int 1992, 50, 24\u201329.","journal-title":"Calcif Tissue Int"},{"key":"BF02210686_CR12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0169-6009(90)90031-A","volume":"11","author":"H.H. Bohr","year":"1990","unstructured":"Bohr, H.H., Schaadt, O.P. Structural changes of the femoral shaft with age measured by dual photon absorptiometry. Bone Miner 1990, 11, 357\u2013362.","journal-title":"Bone Miner"},{"key":"BF02210686_CR13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/8756-3282(90)90052-Z","volume":"11","author":"L. Mosekilde","year":"1990","unstructured":"Mosekilde, L., Mosekilde, L. Sex differences in age-related changes in vertebral body size, density and biomechanical competence in normal individuals. Bone 1990, 11, 67\u201373.","journal-title":"Bone"},{"key":"BF02210686_CR14","first-page":"391","volume":"1","author":"J. Boyle","year":"1970","unstructured":"Boyle, J., Brown, J., Lachance, C. Relation between bone mass and muscle weight. Lancet 1970, 1, 391\u2013393.","journal-title":"Lancet"},{"key":"BF02210686_CR15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0026-0495(89)90081-4","volume":"38","author":"C. Hassager","year":"1989","unstructured":"Hassager, C., P\u00f8denphant, J., Riis, B.J. et al. Changes in soft tissue body composition and plasma lipid metabolism during nandrolone decanoate therapy in postmenopausal osteoporotic women. Metabolism 1989, 38, 238\u2013242.","journal-title":"Metabolism"},{"key":"BF02210686_CR16","unstructured":"Benz, D.J., Kasperk, C., Bard, D., et al. Human osteoblastic osteosarcoma cells exhibit androgen receptors and androgenic responses. Elsevier Science Publishers 1990, 388\u2013394."},{"key":"BF02210686_CR17","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1073\/pnas.86.3.854","volume":"86","author":"C.S. Colvard","year":"1989","unstructured":"Colvard, C.S., Eriksen, E.F., Keeting, P.E., et al. Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci 1989, 86, 854\u2013857.","journal-title":"Proc Natl Acad Sci"},{"key":"BF02210686_CR18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.3388021","volume":"241","author":"E.F. Eriksen","year":"1988","unstructured":"Eriksen, E.F., Colvard, D.S., Berg, N.J., et al. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 1988, 241, 84\u201386.","journal-title":"Science"},{"key":"BF02210686_CR19","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1210\/endo-124-3-1576","volume":"124","author":"C.H. Kasperk","year":"1989","unstructured":"Kasperk, C.H., Wergedal, J.E., Farley, J.R., et al. Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology 1989, 124, 1576\u20131578.","journal-title":"Endocrinology"},{"key":"BF02210686_CR20","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1210\/jcem-71-5-1322","volume":"71","author":"C. Kasperk","year":"1990","unstructured":"Kasperk, C., Fitzsimmons, R., Strong, D., et al. Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone cells. J Clin Endocrin Metab 1990, 71, 1322\u20131329.","journal-title":"J Clin Endocrin Metab"},{"key":"BF02210686_CR21","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1210\/endo-128-6-2723","volume":"128","author":"D.J. Benz","year":"1991","unstructured":"Benz, D.J., Haussler, M.R., Thomas, M.A. et al. High-affinity androgen binding and androgenic regulation of \u03b11 (I)-procollagen and transforming growth factor-\u03b2 steady state messenger ribonucleic acid levels in human osteoblast-like osteosarcoma cells. Endocrinology 1991, 128, 2723\u20132730.","journal-title":"Endocrinology"},{"key":"BF02210686_CR22","unstructured":"Aerssens, J., Peeters, J., Van den Eynde, R., et al. The effect of nandrolone decanoate on IGF-I in rat bone. (Abstract). Fourth Workshop on Cells and Cytokines in Bone and Cartilage, Davos, Switzerland, January 11\u201314, 1992."},{"key":"BF02210686_CR23","first-page":"177","volume":"27","author":"J. Dequeker","year":"1992","unstructured":"Dequeker, J., Mohan, S., Aerssens, J., et al. Correspondence between bone IGF1 concentration and bone density in both humans and rats. (Abstract). Connective Tissue Research 1992, 27, 177.","journal-title":"Connective Tissue Research"},{"issue":"4","key":"BF02210686_CR24","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1210\/endo-125-4-1789","volume":"125","author":"S. Fukayama","year":"1989","unstructured":"Fukayama, S., Tashjian, A.H. Jr. Direct modulation by androgens of the response of human bone cells (SaOS-2) to human parathyroid hormone (PTH) and PTH-related protein. Endocrinology 1989, 125 (4), 1789\u20131794.","journal-title":"Endocrinology"},{"key":"BF02210686_CR25","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/jor.1100080418","volume":"8","author":"R.T. Turner","year":"1990","unstructured":"Turner, R.T., Wakley, G.K., Hannon, K.S. Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female rats. J Orthop Res 1990, 8, 612\u2013617.","journal-title":"J Orthop Res"},{"key":"BF02210686_CR26","first-page":"1389","volume-title":"Effects of ovariectomy, 17\u03b2-oestradiol and nandrolone decanoate on trabecular and cortical bone mass in the rat femur. A quantitative microdensitometrical study","author":"L.P.C. Schot","year":"1990","unstructured":"Schot, L.P.C., Zwamborn, A.W., Trouerbach, W.T.H. In: Effects of ovariectomy, 17\u03b2-oestradiol and nandrolone decanoate on trabecular and cortical bone mass in the rat femur. A quantitative microdensitometrical study. Eds.: Christiansen, C., Overgaard, K., Osteoporosis 1990. Handeltrijkkeriet Aalborg Aps., Aalborg, Denmark, 1389\u20131391."},{"key":"BF02210686_CR27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0039-128X(82)90026-5","volume":"40","author":"J.C. Robin","year":"1982","unstructured":"Robin, J.C., Suh, O.W., Ambrus, J.L. Studies on osteoporosis. VII. Effect of 17\u03b2-hydroxy-4-estren-3-one 17 decanoate on experimental osteoporosis. A preliminary report. Steroids 1982, 40, 125\u2013132.","journal-title":"Steroids"},{"key":"BF02210686_CR28","first-page":"2018","volume-title":"Anabolic and anti-catabolic effects of nandrolone decanoate (Deca-Durbolin\u00ae) on bone or ovariectomised rats","author":"L.P.C. Schot","year":"1990","unstructured":"Schot, L.P.C., Brunekreef, K., Spanjers, C., et al. In: Anabolic and anti-catabolic effects of nandrolone decanoate (Deca-Durbolin\u00ae) on bone or ovariectomised rats. Eds.: Christiansen, C., Overgaard, K., Osteoporosis 1990. Handeltrijkkeriet Aalborg Aps., Aalborg, Denmark, p. 2018\u20132022."},{"key":"BF02210686_CR29","doi-asserted-by":"crossref","unstructured":"Aerssens, J., Van Audekercke, R., Geusens, P., et al. Mechanical properties, bone mineral content and bone composition (collagen, osteocalcin, IGF-1) of the rat femur: influence of ovariectomy and nandrolone decanoate (anabolic steroid). Calcif Tissue Int, in press.","DOI":"10.1007\/BF01320913"},{"key":"BF02210686_CR30","unstructured":"Schot, L.P.C., Dequeker, J., Geusens, P., et al. Effect of long-term nandrolone decanoate treatment on axial and peripheral bone mass and femoral strength in ovariectomised rats. (Abstract). 25th Annual Scanning Micro-scopy and Food Structure Meeting, 11\u201314 May 1992, Chicago, Illinois, USA."},{"key":"BF02210686_CR31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1530\/acta.0.039S037","volume":"39","author":"H. Nowakowski","year":"1962","unstructured":"Nowakowski, H. Metabolic studies with anabolic steroids. Acta Endocrinol 1962, 39, 37\u201353.","journal-title":"Acta Endocrinol"},{"key":"BF02210686_CR32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF02555124","volume":"41","author":"A.G. Need","year":"1987","unstructured":"Need, A.G., Morris, H.A., Hartley, T.F., et al. Effects of nandrolone decanoate on forearm mineral density and calcium metabolism in osteoporotic postmenopausal women. Calcif Tissue Int 1987, 41, 7\u201310.","journal-title":"Calcif Tissue Int"},{"key":"BF02210686_CR33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0378-5122(89)90210-7","volume":"11","author":"C. Gennari","year":"1989","unstructured":"Gennari, C., AgnusDei, D., Gonnelli, S., et al. Effects of nandrolone decanoate therapy on bone mass and calcium metabolism in women with established postmenopausal osteoporosis: a doubleblind placebo-controlled study. Maturitas 1989, 11, 187\u2013197.","journal-title":"Maturitas"},{"key":"BF02210686_CR34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0169-6009(89)90025-1","volume":"6","author":"J.S. Johansen","year":"1989","unstructured":"Johansen, J.S., Hassager, C., P\u00f8denphant, J., et al. Treatment of postmenopausal osteoporosis: is the anabolic steroid nandrolone decanoate a candidate? Bone Miner 1989, 6, 77\u201386.","journal-title":"Bone Miner"},{"key":"BF02210686_CR35","first-page":"347","volume":"1","author":"P. Geusens","year":"1986","unstructured":"Geusens, P., Dequeker, J. Long-term effect of nandrolone decanoate, 1-\u03b1-hydroxyvitamin D3 or intermittent calcium infusion therapy on bone mineral content, bone remodeling and fracture rate in symptomatic osteoporosis: a double-blind controlled study. Bone Miner 1986, 1, 347\u2013357.","journal-title":"Bone Miner"},{"key":"BF02210686_CR36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0378-5122(89)90027-3","volume":"11","author":"C. Hassager","year":"1989","unstructured":"Hassager, C., Riis, B.J., P\u00f8denphant, J., et al. Nandrolone decanoate treatment of post-menopausal osteoporosis for 2 years and effects of withdrawal. Maturitas 1989, 11, 305\u2013317.","journal-title":"Maturitas"},{"key":"BF02210686_CR37","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0169-6009(91)90111-C","volume":"15","author":"S. Adami","year":"1991","unstructured":"Adami, S., Fossaluzza, V., Rossini, M., et al. The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate. Bone Miner 1991, 15, 72\u201381.","journal-title":"Bone Miner"},{"key":"BF02210686_CR38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0026-0495(91)90176-W","volume":"40","author":"C. Hassager","year":"1991","unstructured":"Hassager, C., Jensen, L.T., Johansen, J.S., et al. The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones. Metab Clin Exp 1991, 40, 205\u2013208.","journal-title":"Metab Clin Exp"},{"key":"BF02210686_CR39","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/0026-0495(90)90089-U","volume":"39","author":"C. Hassager","year":"1990","unstructured":"Hassager, C., Jensen, L.T., P\u00f8denphant, J., et al. Collagen synthesis in postmenopausal women during therapy with anabolic steroid or female sex hormones. Metabolism 1990, 39, 1167\u20131169.","journal-title":"Metabolism"},{"key":"BF02210686_CR40","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1210\/jcem-55-6-1124","volume":"55","author":"C. Christiansen","year":"1982","unstructured":"Christiansen, C., Christensen, M.S., Larsen, N.E., et al. Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women. J Clin Endocrinol Metab 1982, 55, 1124\u20131130.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02210686_CR41","doi-asserted-by":"crossref","unstructured":"MacIntyre, I., Stevenson, J.C., Whitehead, M.I., et al. Calcitonin for prevention of postmenopausal bone loss. Lancet 1988, 900\u2013901.","DOI":"10.1016\/S0140-6736(88)91712-6"},{"key":"BF02210686_CR42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199007123230201","volume":"323","author":"N.B. Watts","year":"1990","unstructured":"Watts, N.B., Harris, S.T., Genant, H.K., et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 1990, 323, 73\u201379.","journal-title":"N Engl J Med"},{"key":"BF02210686_CR43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/8756-3282(89)90139-7","volume":"10","author":"A.G. Need","year":"1989","unstructured":"Need, A.G., Horowitz, M., Walker, C.J., et al. Cross-over study of fat-corrected forearm mineral content during nandrolone decanoate therapy for osteoporosis. Bone 1989, 10, 3\u20136.","journal-title":"Bone"},{"key":"BF02210686_CR44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0378-5122(86)90036-8","volume":"8","author":"P. Geusens","year":"1986","unstructured":"Geusens, P., Dequeker, J., Verstraeten, A., et al. Bone mineral content, cortical thickness and fracture rate in osteoporotic women after withdrawal of treatment with nandrolone decanoate, 1-\u03b1 hydroxyvitamin D3, or intermittent calcium infusions. Maturitas 1986, 8, 281\u2013289.","journal-title":"Maturitas"},{"key":"BF02210686_CR45","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0378-5122(86)90035-6","volume":"8","author":"A.G. Need","year":"1986","unstructured":"Need, A.G., Chatterton, B.E., Walker, C.J., et al. Comparison of calcium, calcitriol, ovarian hormones and nandrolone in the treatment of osteoporosis. Maturitas 1986, 8, 275\u2013280.","journal-title":"Maturitas"},{"key":"BF02210686_CR46","first-page":"273","volume":"225","author":"A.G. Need","year":"1987","unstructured":"Need, A.G., Horowitz, M., Morris, H.A., et al. Effects of nandrolone therapy on forearm bone mineral content in osteoporosis. Clin Orthop Rel Res 1987, 225, 273\u2013278.","journal-title":"Clin Orthop Rel Res"},{"key":"BF02210686_CR47","unstructured":"Gonnelli, S., AgnusDei, D., Palmieri, R., et al. Effect of nandrolone decanoate and salmon calcitonin in combination on axial and appendicular bone mass in postmenopausal osteoporosis. In: Osteoporosis 1990. Third International Symposium on Osteoporosis, Copenhagen, Denmark, 14\u201320 October 1990. Eds.: C., Christiansen, K., Overgaard."},{"key":"BF02210686_CR48","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0169-6009(92)90811-Q","volume":"18","author":"J.C. Birkenh\u00e4ger","year":"1992","unstructured":"Birkenh\u00e4ger, J.C., Erdtsieck, R.J., Zeelenberg, J., et al. Can nandrolone add to the effect of hormonal replacement therapy in postmenopausal osteoporosis? Bone Miner 1992, 18, 251\u2013265.","journal-title":"Bone Miner"},{"key":"BF02210686_CR49","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0026-0495(83)90027-6","volume":"32","author":"C.H. Chesnut III.","year":"1983","unstructured":"Chesnut, III. C.H., Ivey, J.L., Gruber, H.E., et al. Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action. Metabolism 1983, 32, 571\u2013580.","journal-title":"Metabolism"},{"key":"BF02210686_CR50","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1136\/bmj.305.6862.1124","volume":"305","author":"J.A. Kanis","year":"1992","unstructured":"Kanis, J.A., Johnell, O., Gullberg, B. et al. Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture. Br Med J 1992, 305, 1124\u20131128.","journal-title":"Br Med J"},{"key":"BF02210686_CR51","unstructured":"Kanis, J.A., Beneton, M.N.C., Johnell, O., et al. Effects of anabolic steroids on cortical bone and hip fracture. (Abstract). 4th International Symposium on Osteoporosis, 27 March\u20132 April 1993, Hong Kong. Abstr 724."},{"issue":"11","key":"BF02210686_CR52","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0026-0495(82)90166-4","volume":"31","author":"H.M.A. Taggart","year":"1982","unstructured":"Taggart, H.M.A., Applebaum-Bowden, D., Haffner, S., et al. Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis. Metabolism 1982, 31, 11, 1147\u20131152.","journal-title":"Metabolism"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02210686.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02210686\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02210686","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T04:12:43Z","timestamp":1586491963000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02210686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,9]]},"references-count":52,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[1995,9]]}},"alternative-id":["BF02210686"],"URL":"https:\/\/doi.org\/10.1007\/bf02210686","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,9]]}}}